STOCK TITAN

Sale of 30,250 EXEL common shares planned under Rule 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder filed a notice of proposed sale under Rule 144 to sell 30,250 shares of common stock of the issuer through Morgan Stanley Smith Barney LLC on 02/13/2026 on NASDAQ. The filing shows an aggregate market value of $1,325,407.81 for these planned sales.

The shares were acquired as restricted stock on 05/31/2025 totaling 21,162 shares with no cash payment noted, and 9,088 shares from a stock option exercise on 02/13/2026 paid in cash. Shares outstanding were 259,708,689 at the time indicated.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Exelixis Inc

NASDAQ:EXEL

EXEL Rankings

EXEL Latest News

EXEL Latest SEC Filings

EXEL Stock Data

11.41B
261.54M
2.23%
96.96%
6.55%
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
ALAMEDA